Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX Discontinuation for Influenza Vaccine in RA
NCT02897011Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2016
- Primary completion
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ARCT-2138 in influenza, sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02897011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897011.